Lee Huang
Overview
Explore the profile of Lee Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tankala R, Huang L, Hiskens M, Vangaveti V, Kandasamy Y, Hariharan G
J Paediatr Child Health
. 2023 Feb;
59(4):680-685.
PMID: 36799108
Aim: High-risk neonates are retrieved from regional centres to tertiary neonatal units when the required care of the baby exceeds the clinical capabilities of the birthing facility. However, there is...
2.
Vittoria M, Kingston N, Kotynkova K, Xia E, Hong R, Huang L, et al.
Nat Commun
. 2022 Jun;
13(1):3732.
PMID: 35768444
Melanoma is commonly driven by activating mutations in the MAP kinase BRAF; however, oncogenic BRAF alone is insufficient to promote melanomagenesis. Instead, its expression induces a transient proliferative burst that...
3.
Huang L, Zhai Y, Fajardo C, Lang D
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008307
More options are needed for the effective treatment of melanoma. In a previous study, we discovered the small molecule drug YK-4-279 almost completely inhibited tumor progression in the ;T; transgenic...
4.
Lui J, Moore S, Huang L, Ogomori K, Li Y, Lang D
Pigment Cell Melanoma Res
. 2021 Sep;
35(1):52-65.
PMID: 34468072
Yes-associated protein 1 (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are transcriptional coactivators that have been implicated in driving metastasis and progression in many cancers, mainly through their transcriptional...
5.
Huang L, Zhai Y, La J, Lui J, Moore S, Little E, et al.
Cancer Res
. 2021 Feb;
81(8):2071-2085.
PMID: 33526511
The failure of once promising target-specific therapeutic strategies often arises from redundancies in gene expression pathways. Even with new melanoma treatments, many patients are not responsive or develop resistance, leading...
6.
Zhai Y, Haresi A, Huang L, Lang D
Pigment Cell Melanoma Res
. 2019 Aug;
33(1):119-121.
PMID: 31449725
No abstract available.
7.
Furtula V, Huang L, Chambers P
J Environ Sci Health B
. 2010 Feb;
44(7):717-23.
PMID: 20183082
Pharmaceuticals are emerging contaminants with potential risks to the environment and human health. A liquid chromatography-tandem mass spectrometry (LC-MS-MS) method was developed for determination of the antimicrobials virginiamycin, monensin, salinomycin,...